Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lipid emulsion as adjuvant therapy for acute clozapine poisoning
PACTR201911916675189Phase 2Completed
- Sponsor
- sara mohsen elsayed basiouny
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of SMOFlipid and clozapine in clozapine poisoning (2 arms), sponsored by sara mohsen elsayed basiouny. Primary endpoint: Improvement of consciousness. Started Mar 2019; status: completed.
02
Drugs
SMOFlipidclozapine
03
Conditions
clozapine poisoning
Beyond the preview
Go deeper on PACTR201911916675189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201911916675189.